Literature DB >> 19640236

Relevance of the aryl hydrocarbon receptor (AhR) for clinical toxicology.

Tracey D Bradshaw1, David R Bell.   

Abstract

INTRODUCTION: The aryl hydrocarbon receptor (AhR) is a cellular signaling molecule infamous for mediating the toxicity of dioxins and related compounds. AIM: The aim of this review is to provide a background of AhR and to examine critically its role in chemical toxicity, in physiological systems, and its interaction with drugs and other compounds. TOXICITY: The AhR is essential for the toxicity of dioxins and related chemicals. The AhR mediates the exquisite sensitivity of animals to dioxins, where as little as 2 ng/kg/day can yield striking adverse effects. PHYSIOLOGICAL ROLE OF AHR: The wide variety of adverse effects of dioxin argues for an important role of the AhR in a variety of physiological systems. Recent investigations have highlighted the role of AhR in the development of the brain and vasculature. DRUGS AND OTHER CHEMICAL ACTIVATORS OF AHR: The development of AhR agonists during drug development programs is sometimes inadvertent, but sometimes the target of development, and is yet further confirmation of the likely importance of AhR signaling in constitutive physiology. The presence of AhR agonists in the diet such as indolo-(3,2-b)-carbazole and 3,3'-diindolylmethane (metabolized from indole 3-carbinol), flavonoids, and sulforaphane and of endogenous activators of this signaling system such as eicosanoids, indirubin, bilirubin, cAMP, and tryptophan are suggestive that AhR activation is a normal physiological process and that it is the persistent and high-level stimulation of AhR by dioxins that is responsible for toxicity.
CONCLUSIONS: AhR-mediated toxicity and physiology are highly relevant to clinical toxicology and drug development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640236     DOI: 10.1080/15563650903140423

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  16 in total

1.  Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol.

Authors:  Mohamed A M El Gendy; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Toxicol Lett       Date:  2011-10-06       Impact factor: 4.372

2.  Detection of Medium-Sized Polycyclic Aromatic Hydrocarbons via Fluorescence Energy Transfer.

Authors:  Nicole Serio; Lindsey Prignano; Sean Peters; Mindy Levine
Journal:  Polycycl Aromat Compd       Date:  2014-08-26

3.  And Now for Something Completely Different: Diversity in Ligand-Dependent Activation of Ah Receptor Responses.

Authors:  Michael S Denison; Samantha C Faber
Journal:  Curr Opin Toxicol       Date:  2017-02

4.  Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms.

Authors:  Mohamed A M El Gendy; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Food Chem Toxicol       Date:  2011-10-21       Impact factor: 6.023

5.  Considerations for potency equivalent calculations in the Ah receptor-based CALUX bioassay: normalization of superinduction results for improved sample potency estimation.

Authors:  David S Baston; Michael S Denison
Journal:  Talanta       Date:  2010-11-19       Impact factor: 6.057

Review 6.  Why toxic equivalency factors are not suitable for perfluoroalkyl chemicals.

Authors:  Jeffrey M Peters; Frank J Gonzalez
Journal:  Chem Res Toxicol       Date:  2011-09-28       Impact factor: 3.739

7.  CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor.

Authors:  Bin Zhao; Danica E Degroot; Ai Hayashi; Guochun He; Michael S Denison
Journal:  Toxicol Sci       Date:  2010-07-15       Impact factor: 4.849

Review 8.  Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies.

Authors:  Cynthia A Thomson; Emily Ho; Meghan B Strom
Journal:  Nutr Rev       Date:  2016-05-31       Impact factor: 7.110

Review 9.  Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.

Authors:  Philip B Busbee; Michael Rouse; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Nutr Rev       Date:  2013-04-01       Impact factor: 7.110

Review 10.  Environmental determinants of chronic disease and medical approaches: recognition, avoidance, supportive therapy, and detoxification.

Authors:  Margaret E Sears; Stephen J Genuis
Journal:  J Environ Public Health       Date:  2012-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.